BlackRock’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-654,355
Closed -$27.3M 5130
2017
Q2
$27.3M Sell
654,355
-29,676
-4% -$1.06M ﹤0.01% 2606
2017
Q1
$21.3M Buy
684,031
+681,831
+30,992% +$23.1M ﹤0.01% 2716
2016
Q4
$77K Hold
2,200
﹤0.01% 2720
2016
Q3
$69K Hold
2,200
﹤0.01% 2811
2016
Q2
$51K Buy
2,200
+1,853
+534% +$44.1K ﹤0.01% 2928
2016
Q1
$8K Buy
+347
New +$8.4K ﹤0.01% 3258
2015
Q2
Sell
-282
Closed -$6K 3319
2015
Q1
$6K Hold
282
﹤0.01% 3002
2014
Q4
$6K Hold
282
﹤0.01% 3030
2014
Q3
$6K Hold
282
﹤0.01% 3042
2014
Q2
$7K Buy
282
+2
+0.7% +$49 ﹤0.01% 3035
2014
Q1
$7K Hold
280
﹤0.01% 2966
2013
Q4
$7K Sell
280
-76
-21% -$1.89K ﹤0.01% 2956
2013
Q3
$8K Hold
356
﹤0.01% 2818
2013
Q2
$7K Buy
+356
New +$6.73K ﹤0.01% 2906

BlackRock's NUTR Position: Q3 2017 in Review

BlackRock sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 654,355 shares — an estimated $27.3M sold.

BlackRock first reported a position in NUTR in Q2 2013 and held it in 14 quarters. The position peaked at $27.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • BlackRock reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • BlackRock sold 654,355 Nutraceutical International Co shares in Q3 2017, an estimated $27.3M.
  • BlackRock first reported a position in Nutraceutical International Co in Q2 2013 and held it in 14 quarters.
  • BlackRock's Nutraceutical International Co position peaked at $27.3M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on BlackRock's 13F filing for Q3 2017, filed 14 Nov 2017.